By Jane Lewis, chief operating officer, chief financial officer and women’s health lead, ABHI For years, the conversation around women’s health has rightly focused on recognition....
WID-easy, the only non-invasive triage test for endometrial cancer in routine use in a European public health system, has been cited in Germany’s highest-tier clinical guidance;...
A sold-out summit at the London Institute for Healthcare Engineering will bring together clinicians, researchers, regulators, investors and founders to discuss how artificial intelligence is being...
The Women and Equalities Committee (WEC) has warned against “financial half measures” on women’s health as the government published its response to the report. Ministers launched...
A major genetics study has found dozens of new signals linked to endometriosis, offering fresh insight into the biology driving the condition. Endometriosis is a systemic...
Women have described being dismissed and left in serious pain during routine hysteroscopy examinations, with many given little or no pain relief. Users of parenting forum...
Health secretary Wes Streeting has relaunched England’s women’s health strategy, vowing to stop women being “gaslit” by doctors. Speaking before publication of the renewed strategy, the...
GSK said its ovarian cancer drug shrank or cleared tumours in more than 60 per cent of patients in an early trial as CCO Luke Miels...
Article produced in association with Spital Clinic Around 1.5 million women in the UK are living with endometriosis — and behind that number is a shared...
Australian startup Proseek Bio has raised AU$1.5m in an oversubscribed seed round to commercialise its ovarian cancer blood test. With up to 80 per cent of...
